EP 1732518 A1 20061220 - CLARITHROMYCIN EXTENDED RELEASE FORMULATION
Title (en)
CLARITHROMYCIN EXTENDED RELEASE FORMULATION
Title (de)
CLARITHROMYCIN-FORMULIERUNG MIT VERLÄNGERTER FREISETZUNG
Title (fr)
FORMULATION A LIBERATION PROLONGEE DE CLARITHROMYCINE
Publication
Application
Priority
- IN 2005000085 W 20050317
- IN 356MU2004 A 20040324
Abstract (en)
[origin: WO2005102289A1] A pharmaceutical composition for extended release of erythromycin or a derivative thereof. the composition comprises comprising a pharmaceutically effective amount of the drug and about 50% to about 65% by weight of one or more pharmaceutically acceptable polymer(s). The pharmaceutically acceptable polymer(s) are selected from the group comprising polyvinyl pyrrolidine, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, methylcellulose, ethyl cellulose, polyvinyl pyrrolidone/polyvinyl acetate copolymers, polyethylene oxide polymers, acrylic acid polymers, methacrylic acid copolymers, natural gums, and derivatives and mixtures thereof.
IPC 8 full level
A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 9/36 (2006.01); A61K 31/7048 (2006.01)
CPC (source: EP)
A61K 9/205 (2013.01); A61K 9/2054 (2013.01); A61K 9/2866 (2013.01); A61K 31/7048 (2013.01)
Citation (search report)
See references of WO 2005102289A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
HR MK
DOCDB simple family (publication)
WO 2005102289 A1 20051103; AU 2005235237 A1 20051103; BR PI0508743 A 20080122; EP 1732518 A1 20061220; MX PA06010805 A 20061219
DOCDB simple family (application)
IN 2005000085 W 20050317; AU 2005235237 A 20050317; BR PI0508743 A 20050317; EP 05764065 A 20050317; MX PA06010805 A 20050317